Total planned funding: $334,167,709
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $68,403,827 |
South Africa | $43,198,562 |
Asia Regional Program | $35,475,616 |
Zambia | $32,903,847 |
Mozambique | $20,993,518 |
Vietnam | $16,390,376 |
West Africa Region | $13,460,980 |
Tanzania | $13,444,411 |
Rwanda | $11,149,961 |
Zimbabwe | $9,054,888 |
Haiti | $8,497,217 |
Dominican Republic | $7,551,779 |
Ethiopia | $7,345,104 |
Burundi | $6,708,625 |
enumerations.Philippines | $6,341,584 |
Cambodia | $5,250,000 |
Kenya | $4,681,243 |
Malawi | $3,988,600 |
Lesotho | $3,392,229 |
Botswana | $2,966,634 |
Uganda | $2,363,740 |
Democratic Republic of the Congo | $2,290,015 |
India | $1,977,954 |
Eswatini | $1,960,500 |
Côte d'Ivoire | $1,888,882 |
China | $1,500,000 |
Western Hemisphere Region | $709,018 |
Thailand | $278,599 |
Indonesia | $0 |
Organizational Types
NGO | $326,497,709 |
Implementing Agency | $7,670,000 |
Program Areas
Prevention | $91,430,288 |
Treatment | $91,075,915 |
Care | $83,406,266 |
Testing | $37,935,514 |
Governance and Systems | $30,319,726 |
Budget Codes
HTXS: Treatment: Adult Treatment | $76,874,506 |
HVOP: Sexual Prevention: Other Sexual Prevention | $39,896,413 |
HVCT: Testing: HIV Testing and Counseling | $37,935,514 |
HKID: Care: Orphans and Vulnerable Children | $36,984,614 |
HBHC: Care: Adult Care and Support | $34,822,646 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,539,294 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,550,673 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,548,440 |
HLAB: Laboratory Infrastructure | $11,332,346 |
HVSI: Strategic Information | $11,121,261 |
HTXD: Treatment: ARV Drugs | $8,505,398 |
OHSS: Health Systems Strengthening | $7,866,119 |
HVTB: Care: TB/HIV | $6,897,716 |
PDTX: Treatment: Pediatric Treatment | $5,696,011 |
PDCS: Care: Pediatric Care and Support | $4,701,290 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,590,468 |
HMIN: Biomedical Prevention: Injection Safety | $245,000 |
HMBL: Biomedical Prevention: Blood Safety | $60,000 |